Narcolepsy
📧 Sign up to get email alerts when something new happens for Narcolepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-10-18FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for Amphetamine Sulfate from Solco Healthcare US, LLC.
-
FDA approval · 2023-10-18FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for Rhodes Pharmaceuticals L.P. for a four-ingredient amphetamine product (dextroamphetamine sacchar…
-
FDA approval · 2023-10-17FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Amphetamine sulfate from Granules Pharmaceuticals Inc. to support a formulation change to a gran…
-
FDA approval · 2023-10-16FDA Approved: AMPHETAMINE SULFATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for amphetamine sulfate (Amneal Pharmaceuticals NY LLC), resulting in an updated regulatory approval…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a four-salt combination product containing dextroamphetamine saccharate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-10-13FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for METHYLIN (methylphenidate hydrochloride) from Shionogi Inc., potentially updating the label or i…
-
FDA approval · 2023-10-13FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for methylphenidate (Sandoz Inc) to update the product labeling under the NDA.
-
FDA approval · 2023-10-13FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for dextroamphetamine sulfate (generic).
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application by Teva for a four-salt amphetamine product consisting of dextroamphetamine saccharate, amphetamine …
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Epic Pharma, LLC)
FDA approves Epic Pharma, LLC's supplemental application for a generic product containing dextroamphetamine saccharate, amphetamine aspartat…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc for a generic combination product containing four amphetamine salts (dextroamphetami…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for a generic dextr oamphetamine sulfate product from Lupin Pharmaceuticals, authorizing its continu…
-
FDA approval · 2023-10-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from Rising Pharma Holdings, Inc., authorizing its continued marke…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SUNRISE PHARMACEUTICAL, INC.)
The FDA approved a supplemental application for dextroamphetamine sulfate submitted by Sunrise Pharmaceutical, Inc.
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SUNRISE PHARMACEUTICAL, INC.)
The FDA approved Sunrise Pharmaceutical's supplemental application for a four-salt amphetamine product (dextroamphetamine saccharate, amphet…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental application for a generic combination product containing four amphetamine salts: dextroamp…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for a combination amphetamine/dextroamphetamine product from Granules Pharmaceuticals Inc. containin…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Supplemental Application (Neolpharma, Inc.)
FDA approved a supplemental application for a generic combination of dextroamphetamine and amphetamine salts manufactured by Neolpharma, Inc…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a supplemental application for dextroamphetamine sulfate (generic) from Cranbury Pharmaceuticals, enabling the marketing of…
-
FDA approval · 2023-10-13FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EVEKEO (amphetamine sulfate) submitted by Azurity Pharmaceuticals, Inc.
-
FDA approval · 2023-10-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for methylphenidate hydrochloride from Trigen Laboratories, LLC.
-
FDA label_change · 2023-10-13FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) submitted by Amneal Pharmaceuticals LLC. This…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application from Sun Pharmaceutical Industries for a generic product comprising four amphetamine salt compon…
-
FDA approval · 2023-10-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from Camber Pharmaceuticals Inc., confirming approval of a generic…